Moreover, DCLK1 is overexpressed in colorectal [15, 16, 58, 59], pancreatic [20, 21, 60], hepatocellular [24], breast [18, 19], and bladder cancers [61], suggesting its widespread activation during oncogenesis. This evidence concerns the gene DCLK1 and urinary bladder carcinoma.